A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

PHASE2UnknownINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions
Nasopharyngeal NeoplasmsSalivary Gland DiseasesBone Marrow DiseasesMucositis
Interventions
DRUG

Amifostine every-other-day regimen

Amifostine 400mg/d, every-other-day regimen from Monday to Friday, every week repetition during radiotherapy

DRUG

Amifostine everyday regimen

Amifostine 400mg/d, everyday regimen from Monday to Friday, every week repetition during radiotherapy

Trial Locations (7)

510010

SUSPENDED

The Main Guangzhou Hospital of the Guangzhou Military Region, Guangzhou

510060

RECRUITING

Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou

510095

SUSPENDED

The Affiliated Cancer Hospital Of Guangzhou Medical Collage, Guangzhou

510120

SUSPENDED

Guangdong Provincial Hospital Of Chinese Medicine, Guangzhou

RECRUITING

The First Affiliated Hospital Of Guangzhou Medical Collage, Guangzhou

510260

SUSPENDED

The Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou

510317

WITHDRAWN

Guangdong Second People's Hospital, Guangzhou

Sponsors
All Listed Sponsors
collaborator

Dalian Merro Pharmaceutical Co. Ltd

UNKNOWN

lead

Sun Yat-sen University

OTHER